SCHEMBL17722265

SCHEMBL17722265

c1ccc(-c2ccc3c4ccccc4n(-c4cccc(-c5cccc(N(c6ccccc6)c6ccccc6)c5)c4)c3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ TSPO P30536 1/20 0.36
▸ RXRA P19793 1/20 0.35
▸ RXRB P28702 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HTT P42858 2/20 0.35
▸ FAAH O00519 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ MGLL Q99685 1/20 0.35
▸ OPRD1 P41143 1/20 0.34
▸ KMT2A Q03164 3/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24943631 0.96 ATM (0.46) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL16947131 0.96 L3MBTL1 (0.50) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL17056423 0.96 L3MBTL1 (0.50) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL16947059 0.96 L3MBTL1 (0.50) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL16947142 0.95 L3MBTL1 (0.49) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL19738266 0.95 L3MBTL1 (0.49) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL17056419 0.95 L3MBTL1 (0.49) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL23663682 0.95 L3MBTL1 (0.49) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL16947126 0.95 L3MBTL1 (0.49) ATML3MBTL1KDM4ETSPORXRA
SCHEMBL19738316 0.95 L3MBTL1 (0.49) ATML3MBTL1KDM4ETSPORXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170331067-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS SAMSUNG SDI CO., LTD. (KR) 2017-11-16 — — US disclosed
US-20170331067-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS SAMSUNG SDI CO., LTD. (KR) 2017-11-16 — — US disclosed
US-20160126471-A1 ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-05-05 — — US disclosed
US-20160126471-A1 ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170331067-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS ALDH1A2, AOX1, AOC2 ATM 3243/4885L3MBTL1 4413/4885KDM4E 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback